Please wait a minute...
文章检索
预防医学  2025, Vol. 37 Issue (4): 395-399    DOI: 10.19485/j.cnki.issn2096-5087.2025.04.016
  疾病控制 本期目录 | 过刊浏览 | 高级检索 |
2009—2023年湖州市HIV/AIDS病例新发现率趋势分析
王洪岩, 任飞林, 刘小琦, 金玫华, 吴振乾
湖州市疾病预防控制中心,浙江 湖州 313000
Trend in new diagnosis rates of HIV/AIDS cases in Huzhou City from 2009 to 2023
WANG Hongyan, REN Feilin, LIU Xiaoqi, JIN Meihua, WU Zhenqian
Huzhou Center for Disease Control and Prevention, Huzhou, Zhejiang 313000, China
全文: PDF(962 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 分析2009—2023年浙江省湖州市艾滋病病毒感染者和艾滋病患者(HIV/AIDS)新发现率趋势,为完善艾滋病防治策略提供依据。方法 通过中国疾病预防控制信息系统收集2009—2023年湖州市新报告HIV/AIDS病例资料,以1年内新报告HIV/AIDS病例数占同期常住人口数的比例计算新发现率,描述性分析不同性别、年龄和地区HIV/AIDS病例新发现率,采用平均年度变化百分比(AAPC)和年度变化百分比(APC)分析变化趋势。结果 2009—2023年湖州市新报告HIV/AIDS病例2 088例,年均新发现率为4.53/10万。2009—2023年HIV/AIDS病例新发现率整体呈上升趋势(AAPC=12.745%,P<0.05),其中2009—2015年快速上升(APC=32.734%,P<0.05),2015—2023年无变化趋势(P>0.05)。男性HIV/AIDS病例年均新发现率为7.54/10万,高于女性的1.40/10万(P<0.05);男性HIV/AIDS病例新发现率趋势与全人群基本一致;女性呈持续上升趋势,无明显拐点(AAPC=12.575%,P<0.05)。<25岁、25~<50岁和≥50岁组HIV/AIDS病例年均新发现率分别为2.75/10万、6.16/10万和3.83/10万,<25岁组新发现率整体无变化趋势(P>0.05),25~<50岁和≥50岁组新发现率趋势与全人群基本一致。吴兴区、南浔区、德清县、长兴县和安吉县HIV/AIDS病例年均新发现率分别为6.54/10万、3.43/10万、3.45/10万、3.56/10万和4.94/10万,整体均呈上升趋势(AAPC=9.672%、27.599%、11.800%、18.896%和10.254%,均P<0.05)。结论 2009—2023年湖州市HIV/AIDS病例新发现率整体呈上升趋势,男性、25~<50岁和吴兴区病例相对集中,是艾滋病防控的重点。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
王洪岩
任飞林
刘小琦
金玫华
吴振乾
关键词 艾滋病新发现率平均年度变化百分比年度变化百分比    
AbstractObjective To analyze the trends in new diagnosis rates of HIV/AIDS cases in Huzhou City, Zhejiang Province from 2009 to 2023, so as to provide the basis for improving HIV/AIDS prevention and control strategies. Methods Data of newly reported HIV/AIDS cases in Huzhou City from 2009 to 2023 were collected through the Chinese Disease Prevention and Control Information System. The new diagnosis rate was calculated as the ratio of newly reported HIV/AIDS cases within one year to the permanent resident population during the same period. The gender, age, and regional distribution characteristics of new diagnosis rates of HIV/AIDS cases were described. The trends were analyzed using average annual percent change (AAPC) and annual percent change (APC). Results A total of 2 088 new HIV/AIDS cases were reported in Huzhou City from 2009 to 2023, with an average annual new diagnosis rate of 4.53/105. The new diagnosis rates showed an overall increasing trend from 2009 to 2023 (AAPC=12.745%, P<0.05), with rapid growth during 2009 to 2015 (APC=32.734%, P<0.05) but no significant trend during 2015 to 2023 (P>0.05). The average annual new diagnosis rate was significantly higher in males than in females (7.54/105 vs. 1.40/105, P<0.05). Male new diagnosis rate trend closely mirrored the overall population pattern, while females showed a continuous upward trend without clear inflection point (AAPC=12.575%, P<0.05). Age-specific analysis revealed average annual new diagnosis rates of 2.75/105, 6.16/105 and 3.83/105 for AIDS/HIV cases aged <25, 25-<50 and ≥50 years, respectively. The cases aged <25 years showed no significant trend (P>0.05), while the cases aged 25-<50 and ≥50 years followed patterns similar to the overall population. The average annual new diagnosis rates of HIV/AIDS cases in Wuxing District, Nanxun District, Deqing County, Changxing County and Anji County were 6.54/105, 3.43/105, 3.45/105, 3.56/105 and 4.94/105, respectively, showing overall upward trends (AAPC=9.672%, 27.599%, 11.800%, 18.896% and 10.254%, all P<0.05). Conclusions The new diagnosis rate of HIV/AIDS cases showed an overall upward trend in Huzhou City from 2009 to 2023. Cases are mainly concentrated among males, people aged 25-<50 years and Wuxing District, making them key targets for HIV/AIDS prevention and control.
Key wordsAIDS    new diagnosis rate    average annual percent change    annual percent change
收稿日期: 2024-11-25      修回日期: 2025-01-22      出版日期: 2025-04-10
中图分类号:  R512.91  
基金资助:湖州市科技计划项目(2022GYB13)
作者简介: 王洪岩,硕士,医师,主要从事艾滋病防治工作
通信作者: 刘小琦,E-mail:9218118@qq.com   
引用本文:   
王洪岩, 任飞林, 刘小琦, 金玫华, 吴振乾. 2009—2023年湖州市HIV/AIDS病例新发现率趋势分析[J]. 预防医学, 2025, 37(4): 395-399.
WANG Hongyan, REN Feilin, LIU Xiaoqi, JIN Meihua, WU Zhenqian. Trend in new diagnosis rates of HIV/AIDS cases in Huzhou City from 2009 to 2023. Preventive Medicine, 2025, 37(4): 395-399.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2025.04.016      或      http://www.zjyfyxzz.com/CN/Y2025/V37/I4/395
[1] The Joint United Nations Programme on HIV/AIDS.Global HIV&AIDS statistics—Fact sheet[EB/OL].[2025-01-22].https://www.unaids.org/en/resources/fact-sheet.
[2] 中国疾病预防控制中心性病艾滋病预防控制中心.2023年12月全国艾滋病性病疫情[J].中国艾滋病性病,2024,30(3):225.
National Center for AIDS/STD Control and Prevention,Chinese Center for Disease Control and Prevention.December 2023 national AIDS STD epidemic[J].Chin J AIDS STD,2024,30(3):225.(in Chinese)
[3] 国务院办公厅.国务院办公厅关于印发中国遏制与防治艾滋病“十二五”行动计划的通知[J].中华人民共和国国务院公报,2012(7):7-14.
[4] 国务院办公厅.国务院办公厅关于印发中国遏制与防治艾滋病“十三五”行动计划的通知[J].中华人民共和国国务院公报,2017(6):102-108.
[5] 孟忠华,陈安心,吕豪,等.浙江省采取综合措施阻断经输血传播HIV的探索[J].中国输血杂志,2015,28(8):885-887.
MENG Z H,CHEN A X,LYU H,et al.Exploration of the "cocktail therapy" in Zhejiang province by blocking HlV transmission via blood transfusion[J].Chin J Blood Transfusion,2015,28(8):885-887.(in Chinese)
[6] 陈卫永,马瞧勤,程伟,等.浙江省艾滋病疫情重点县区防控策略SWOT分析[J].预防医学,2022,34(1):78-82.
CHEN W Y,MA Q Q,CHENG W,et al.SWOT analysis of HIV control strategy in key areas of Zhejiang Province[J].China Prev Med J,2022,34(1):78-82.(in Chinese)
[7] 傅天颖,吴昊澄,鲁琴宝,等.2023年浙江省法定传染病疫情分析[J].预防医学,2024,36(5):369-373.
FU T Y,WU H C,LU Q B,et al.Analysis of notifiable infectious diseases in Zhejiang Province in 2023[J].China Prev Med J,2024,36(5):369-373.(in Chinese)
[8] 蔡畅,汤后林,陈方方,等.我国2010—2019年新报告青年学生HIV/AIDS基本特征及趋势分析[J].中华流行病学杂志,2020,41(9):1455-1459.
CAI C,TANG H L,CHEN F F,et al.Characteristics and trends of newly reported HIV infection in young students in China,2010-2019[J].Chin J Epidemiol,2020,41(9):1455-1459.(in Chinese)
[9] 顾晓敏,姜海波,史宏博,等.2010—2018年宁波市医疗机构HIV抗体检测及HIV/AIDS病例现况调查[J].中国公共卫生管理,2022,38(5):660-662.
GU X M,JIANG H B,SHI H B,et al.HIV antibody test and HlV/AlDS cases detection from 2010 to 2018 in medicainstitutions in Ningbo city[J].Chin J of PHM,2022,38(5):660-662.(in Chinese)
[10] LIU S L,LUO L P,XI G X,et al.Seroprevalence and risk factors on Syphilis among blood donors in Chengdu,China,from2005 to 2017[J/OL].BMC Infect Dis,2019,19(1)[2025-01-22].https://doi.org/10.1186/s12879-019-4128-7.
[11] BAI B K,JIANG Q Y,HOU J.The COVID-19 epidemic and other notifiable infectious diseases in China[J/OL].Microbes Infect,2022[2025-01-22].https://doi.org/10.1016/j.micinf.2021.104881.
[12] GUO R L,MCALEESE W J,APPLEBY K M,et al.Predictors of intention to use condoms among Chinese college students[J].J Community Health,2014,39(4):712-718.
[13] 唐慧玲,蒋均,虞娓娜,等.浙江省一起非婚非商业异性性传播HIV聚集性疫情调查[J].中华流行病学杂志,2023,44(8):1270-1275.
TANG H L,JIANG J,YU W N,et al.A clustered epidemic investigation of non-marital non-commercial heterosexual contact of HIV in Zhejiang Province[J].Chin J Epidemiol,2023,44(8):1270-1275.(in Chinese)
[14] LIN Q,DENG B,RUI J,et al.Epidemiological characteristics and transmissibility of human immunodeficiency virus in Nanning city,China,2001-2020[J/OL].Front Public Health,2021,9[2025-01-22].https://doi.org/10.3389/fpubh.2021.689575.
[15] CAO D Q,XING H,FENG Y,et al.Molecular transmission network analysis reveals the challenge of HIV-1 in ageing patients in China:elderly people play a crucial role in the transmission of subtypes and high pretreatment drug resistance in developed Eastern China,2019-2023[J/OL].Virol J,2024,21(1)[2025-01-22].https://doi.org/10.1186/s12985-024-02455-2.
[16] 朱玲,鲍梦隐.共同富裕示范区的城乡融合发展探析——以浙江省湖州市为例[J].江苏航运职业技术学院学报,2023,22(2):99-104.
ZHU L,BAO M Y.An analysis on the development of urban and rural integration in the co-prosperity demonstration zone:a case study of Huzhou City,Zhejiang Province[J].J JiangSu Shipp Coll,2023,22(2):99-104.(in Chinese)
[17] 潘杰,许向东.2010—2014年湖州市南浔区男性流动人群艾滋病哨点监测结果[J].江苏预防医学,2016,27(4):443-444.
PAN J,XU X D.HIV sentinel surveillance results of male floating population in Nanxun District,Huzhou City from 2010 to 2014[J].Jiangsu J Prev Med,2016,27(4):443-444.(in Chinese)
[18] 王强,翁士增,董喆.外来人口流入湖州的成因、影响及对策[J].湖州职业技术学院学报,2022,20(2):78-83,94.
WANG Q,WENG S Z,DONG Z.The causes,effects and countermeasures of the migrants inflow to Huzhou[J].J Huzhou Vocational and Technol Coll,2022,20(2):78-83,94.(in Chinese)
[1] 任露露, 顾嘉昌, 闵艺璇, 张思晨, 乔健健, 肖月, 胡静. 2016—2023年宜兴市脑卒中发病趋势分析[J]. 预防医学, 2025, 37(5): 498-502.
[2] 李慧君, 叶振淼, 樊丽辉, 郑宇航, 谢轶敏, 姜雪霞, 高豪俊, 张默涵, 罗永园. 2015—2023年温州市老年人跌倒死亡趋势与减寿分析[J]. 预防医学, 2025, 37(5): 460-464.
[3] 李瑶, 杨景元, 杨虹, 李向春, 孔瑞琴, 刘静, 白宝宝, 张艳萍, 李慧. 内蒙古自治区艾滋病自愿咨询检测门诊求询者特征分析[J]. 预防医学, 2025, 37(4): 356-360.
[4] 李倩, 杨柏林, 陈积标, 尹寒露, 许祝平, 孟晓军. 无锡市50岁及以上HIV/AIDS抗病毒治疗病例自报慢性病资料分析[J]. 预防医学, 2025, 37(4): 390-394.
[5] 叶振淼, 樊丽辉, 姜雪霞, 郑宇航, 张默涵, 罗永园, 谢轶敏, 李慧君, 金茜. 2014—2023年温州市胃癌死亡及减寿趋势分析[J]. 预防医学, 2025, 37(3): 267-271.
[6] 王苓, 许珂, 张兴亮, 黄思超, 李西婷, 陈珺芳. 2022年杭州市新报告HIV/AIDS病例感染特征分析[J]. 预防医学, 2025, 37(2): 123-129.
[7] 裘凤黔, 赵俊峰, 陈玮华, 杜娟, 纪云芳, 高淑娜, 蒙洁, 何丽华, 陈博, 张艳. 2002—2019年黄浦区肺癌发病和死亡趋势分析[J]. 预防医学, 2025, 37(2): 143-147.
[8] 温佳鑫, 蒋俊鹏, 冯敏, 沈晓晨, 李晓印. 1990—2021年中国类风湿关节炎疾病负担趋势分析[J]. 预防医学, 2025, 37(1): 26-30.
[9] 章群, 王永, 陈洁平, 包凯芳, 冯玥溢, 王小丽. 2011—2023年宁波市前列腺癌发病和死亡趋势分析[J]. 预防医学, 2025, 37(1): 46-50.
[10] 叶振淼, 樊丽辉, 郑宇航, 姜雪霞, 李慧君, 张默涵, 谢轶敏, 罗永园, 金茜. 温州市乳腺癌死亡及减寿分析[J]. 预防医学, 2024, 36(9): 746-749.
[11] 丁晨, 刘家虹, 吴争, 熊长辉. 江西省部分地区HIV/AIDS病例HIV-1分子传播网络分析[J]. 预防医学, 2024, 36(9): 764-767.
[12] 戴色莺, 沈月兰, 刘爱文, 张进, 吴家兵. 安徽省男性流动人口艾滋病相关知识和HIV感染情况调查[J]. 预防医学, 2024, 36(8): 674-678,682.
[13] 王慧, 李锦成, 陆兴, 王金富, 竺丽梅, 刘巧. 重组结核杆菌融合蛋白皮肤试验筛查HIV/AIDS病例结核分枝杆菌潜伏感染的效果分析[J]. 预防医学, 2024, 36(7): 639-643.
[14] 何婷婷, 曹栋卿, 林家锋, 蒋卓婧, 张佳峰, 范钦. 绍兴市MSM人群HIV-1分子传播网络特征分析[J]. 预防医学, 2024, 36(7): 571-575,579.
[15] 贾晓锋, 王慧群, 石敏, 汤婕, 任静霞. HIV/AIDS病例HIV相关神经认知障碍的影响因素分析[J]. 预防医学, 2024, 36(6): 461-464.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed